Answers are grounded in this paper and cite their sources.
A neoantigen-based vaccine elicits T cell responses in cancer patients [Also see Report by Carreno et al. ]
No takes yet. Share an insight, caveat, or question.
Delamarre et al. (2015) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: